China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
1.500
+0.010 (0.67%)
Last updated: Sep 30, 2025, 5:15 PM CET
0.67%
Market Cap3.70B
Revenue (ttm)934.24M
Net Income (ttm)196.19M
Shares Outn/a
EPS (ttm)0.08
PE Ratio18.88
Forward PE16.79
Dividend0.03 (2.16%)
Ex-Dividend DateAug 29, 2025
Volumen/a
Average Volume668
Open1.500
Previous Close1.490
Day's Range1.500 - 1.500
52-Week Range0.805 - 1.650
Betan/a
RSI44.27
Earnings DateNov 18, 2025

About FRA:2M7C

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 6,141
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.